Stereotactic radiotherapy in the management of oligometastatic and recurrent head and neck cancer: a single-center experience.
Ahmed Allam MohamedMiguel GoncalvesBiney Pal SinghMareike TomettenAshkan RashadFrank HölzleStephan HackenbergMichael EblePublished in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2023)
Stereotactic radiotherapy demonstrated favorable outcomes in patients with OMD/R-HNC with limited toxicities. Further studies are warranted to validate these findings and optimize treatment strategies for this patient population.